These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 39411709)

  • 1. Virological characteristics of SARS-CoV-2 Omicron BA.5.2.48.
    Wang W; Jin Q; Liu R; Zeng W; Zhu P; Li T; Wang T; Xiang H; Zhang H; Chen Q; Gao Y; Lai Y; Yan F; Xia X; Li J; Wang X; Gao Y
    Front Immunol; 2024; 15():1427284. PubMed ID: 39411709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission.
    Benlarbi M; Ding S; Bélanger É; Tauzin A; Poujol R; Medjahed H; El Ferri O; Bo Y; Bourassa C; Hussin J; Fafard J; Pazgier M; Levade I; Abrams C; Côté M; Finzi A
    mBio; 2024 Aug; 15(8):e0090724. PubMed ID: 38953636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice.
    Ogger PP; Martín MG; Jang S; Zhou J; Brown J; Sukhova K; Furnon W; Patel AH; Cowton V; Palmarini M; Barclay WS; Johansson C
    Front Immunol; 2024; 15():1383612. PubMed ID: 38742107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.
    Niu S; Zhao Z; Liu Z; Rong X; Chai Y; Bai B; Han P; Shang G; Ren J; Wang Y; Zhao X; Liu K; Tian W-x; Wang Q; Gao GF
    J Virol; 2024 Mar; 98(3):e0115723. PubMed ID: 38305152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses.
    Pérez P; Astorgano D; Albericio G; Flores S; Sánchez-Corzo C; Noriega MA; Sánchez-Cordón PJ; Labiod N; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
    Front Immunol; 2024; 15():1420304. PubMed ID: 39267752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
    Case JB; Scheaffer SM; Darling TL; Bricker TL; Adams LJ; Harastani HH; Trende R; Sanapala S; Fremont DH; Boon ACM; Diamond MS
    J Virol; 2023 Sep; 97(9):e0062823. PubMed ID: 37676002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3.
    Liu Y; Zhao X; Shi J; Wang Y; Liu H; Hu YF; Hu B; Shuai H; Yuen TT; Chai Y; Liu F; Gong HR; Li J; Wang X; Jiang S; Zhang X; Zhang Y; Li X; Wang L; Hartnoll M; Zhu T; Hou Y; Huang X; Yoon C; Wang Y; He Y; Zhou M; Du L; Zhang X; Chan WM; Chen LL; Cai JP; Yuan S; Zhou J; Huang JD; Yuen KY; To KK; Chan JF; Zhang BZ; Sun L; Wang P; Chu H
    Nat Commun; 2024 Oct; 15(1):8728. PubMed ID: 39379369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants.
    Yang H; Guo H; Wang A; Cao L; Fan Q; Jiang J; Wang M; Lin L; Ge X; Wang H; Zhang R; Liao M; Yan R; Ju B; Zhang Z
    Nat Commun; 2024 Sep; 15(1):7715. PubMed ID: 39231977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
    Kimura I; Yamasoba D; Nasser H; Ito H; Zahradnik J; Wu J; Fujita S; Uriu K; Sasaki J; Tamura T; Suzuki R; Deguchi S; Plianchaisuk A; Yoshimatsu K; Kazuma Y; Mitoma S; Schreiber G; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Takaori-Kondo A; ; Ito J; Shirakawa K; Takayama K; Irie T; Hashiguchi T; Nakagawa S; Fukuhara T; Saito A; Ikeda T; Sato K
    J Virol; 2023 Oct; 97(10):e0101123. PubMed ID: 37796123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5.
    Kimura I; Yamasoba D; Tamura T; Nao N; Suzuki T; Oda Y; Mitoma S; Ito J; Nasser H; Zahradnik J; Uriu K; Fujita S; Kosugi Y; Wang L; Tsuda M; Kishimoto M; Ito H; Suzuki R; Shimizu R; Begum MM; Yoshimatsu K; Kimura KT; Sasaki J; Sasaki-Tabata K; Yamamoto Y; Nagamoto T; Kanamune J; Kobiyama K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Shirakawa K; Takaori-Kondo A; Kuramochi J; Schreiber G; Ishii KJ; ; Hashiguchi T; Ikeda T; Saito A; Fukuhara T; Tanaka S; Matsuno K; Sato K
    Cell; 2022 Oct; 185(21):3992-4007.e16. PubMed ID: 36198317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.
    Yamasoba D; Kimura I; Nasser H; Morioka Y; Nao N; Ito J; Uriu K; Tsuda M; Zahradnik J; Shirakawa K; Suzuki R; Kishimoto M; Kosugi Y; Kobiyama K; Hara T; Toyoda M; Tanaka YL; Butlertanaka EP; Shimizu R; Ito H; Wang L; Oda Y; Orba Y; Sasaki M; Nagata K; Yoshimatsu K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Kuramochi J; Seki M; Fujiki R; Kaneda A; Shimada T; Nakada TA; Sakao S; Suzuki T; Ueno T; Takaori-Kondo A; Ishii KJ; Schreiber G; ; Sawa H; Saito A; Irie T; Tanaka S; Matsuno K; Fukuhara T; Ikeda T; Sato K
    Cell; 2022 Jun; 185(12):2103-2115.e19. PubMed ID: 35568035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents.
    Uraki R; Halfmann PJ; Iida S; Yamayoshi S; Furusawa Y; Kiso M; Ito M; Iwatsuki-Horimoto K; Mine S; Kuroda M; Maemura T; Sakai-Tagawa Y; Ueki H; Li R; Liu Y; Larson D; Fukushi S; Watanabe S; Maeda K; Pekosz A; Kandeil A; Webby RJ; Wang Z; Imai M; Suzuki T; Kawaoka Y
    Nature; 2022 Dec; 612(7940):540-545. PubMed ID: 36323336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2.
    Hu B; Chan JF; Liu H; Liu Y; Chai Y; Shi J; Shuai H; Hou Y; Huang X; Yuen TT; Yoon C; Zhu T; Zhang J; Li W; Zhang AJ; Zhou J; Yuan S; Zhang BZ; Yuen KY; Chu H
    Emerg Microbes Infect; 2022 Dec; 11(1):2275-2287. PubMed ID: 36039901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spike receptor-binding motif G496S substitution determines the replication fitness of SARS-CoV-2 Omicron sublineage.
    Liang R; Ye ZW; Ong CP; Qin Z; Xie Y; Fan Y; Tang K; Poon VK; Chan CC; Yang X; Cao H; Wang K; Sun H; Hu B; Cai JP; Luo C; Chik KK; Chu H; Zheng Y; Yuen KY; Chan JF; Jin DY; Yuan S
    Emerg Microbes Infect; 2022 Dec; 11(1):2093-2101. PubMed ID: 35943779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.
    Neerukonda SN; Wang R; Vassell R; Baha H; Lusvarghi S; Liu S; Wang T; Weiss CD; Wang W
    J Virol; 2022 Sep; 96(17):e0114022. PubMed ID: 36000843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
    Cao Y; Yisimayi A; Jian F; Song W; Xiao T; Wang L; Du S; Wang J; Li Q; Chen X; Yu Y; Wang P; Zhang Z; Liu P; An R; Hao X; Wang Y; Wang J; Feng R; Sun H; Zhao L; Zhang W; Zhao D; Zheng J; Yu L; Li C; Zhang N; Wang R; Niu X; Yang S; Song X; Chai Y; Hu Y; Shi Y; Zheng L; Li Z; Gu Q; Shao F; Huang W; Jin R; Shen Z; Wang Y; Wang X; Xiao J; Xie XS
    Nature; 2022 Aug; 608(7923):593-602. PubMed ID: 35714668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance.
    Raisinghani N; Alshahrani M; Gupta G; Verkhivker G
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5.
    Shuai H; Chan JF; Hu B; Chai Y; Yoon C; Liu H; Liu Y; Shi J; Zhu T; Hu JC; Hu YF; Hou Y; Huang X; Yuen TT; Wang Y; Zhang J; Xia Y; Chen LL; Cai JP; Zhang AJ; Yuan S; Zhou J; Zhang BZ; Huang JD; Yuen KY; To KK; Chu H
    EBioMedicine; 2023 Sep; 95():104753. PubMed ID: 37579626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 omicron BA.2.87.1 exhibits higher susceptibility to serum neutralization than EG.5.1 and JN.1.
    Wang Q; Guo Y; Schwanz LT; Mellis IA; Sun Y; Qu Y; Urtecho G; Valdez R; Stoneman E; Gordon A; Wang HH; Ho DD; Liu L
    Emerg Microbes Infect; 2024 Dec; 13(1):2359004. PubMed ID: 38779718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants.
    Mühlemann B; Trimpert J; Walper F; Schmidt ML; Jansen J; Schroeder S; Jeworowski LM; Beheim-Schwarzbach J; Bleicker T; Niemeyer D; Richter A; Adler JM; Vidal RM; Langner C; Vladimirova D; Wilks SH; Smith DJ; Voß M; Paltzow L; Martínez Christophersen C; Rose R; Krumbholz A; Jones TC; Corman VM; Drosten C
    Proc Natl Acad Sci U S A; 2024 Aug; 121(32):e2310917121. PubMed ID: 39078681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.